Provided by Tiger Trade Technology Pte. Ltd.

Liquidia Technologies Inc

67.22
-1.9000-2.75%
Volume:133.55K
Turnover:9.02M
Market Cap:6.02B
PE:48.01
High:68.20
Open:67.87
Low:67.03
Close:69.12
52wk High:93.61
52wk Low:21.15
Shares:89.51M
Float Shares:70.82M
Volume Ratio:1.23
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.40
EPS(LYR):-0.8009
ROE:131.82%
ROA:27.04%
PB:30.84
PE(LYR):-83.93

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)

TIPRANKS
·
Yesterday

Liquidia granted Fast Track designation to Yutrepia inhalation powder

TIPRANKS
·
Sep 03

Liquidia Corporation - FDA Grants Fast Track Designation to Yutrepia for Ssc-Rp

THOMSON REUTERS
·
Sep 03

Liquidia Corporation - Re-Warm Study Expected to Begin October 2026 with Primary Completion February 2027

THOMSON REUTERS
·
Sep 03

Liquidia Corporation - to Initiate Re-Warm Phase 2a Study of Yutrepia in Ssc-Rp in Q4 2026

THOMSON REUTERS
·
Sep 03

Wells Fargo Sticks to Their Buy Rating for Liquidia Technologies (LQDA)

TIPRANKS
·
Sep 02

Liquidia Launches Phase 3 Re-Spire Trial of L606 Inhaled Treprostinil in PH-ILD

Reuters
·
Sep 02

Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference

GlobeNewswire
·
Sep 01

Liquidia Chief Business Officer Jason Adair Reports Disposal of 73,631 Common Shares Worth $5.09 Million

Reuters
·
Aug 26

Liquidia Director Katherine Rielly-Gauvin Reports Common Share Sale Worth $4.08 Million

Reuters
·
Aug 22

Liquidia Chief Medical Officer Rajeev Saggar Disposes of USD 5.97 Million in Common Shares

Reuters
·
Aug 20

Liquidia Technologies (LQDA) Gets a Buy from Wells Fargo

TIPRANKS
·
Aug 19

Movement Alert|Liquidia Technologies Inc Falls 5.1% in Regular Trading, Q2 EPS Misses Expectations Extending Post-Earnings Profit-Taking

Market Focus
·
Aug 18

Liquidia price target raised to $92 from $79 at BofA

TIPRANKS
·
Aug 17

Cloudflare Stock And 2 High Growth Picks For AI And Cloud Security

Simply Wall St.
·
Aug 15

Movement Alert|Liquidia Technologies Inc Rises 5.18% in Regular Trading, Rebounding After Two-Day Post-Earnings Pullback on Strong Revenue Beat

Market Focus
·
Aug 14

Quince Therapeutics Q2 Net Loss Widens on Acquisition Charges

Reuters
·
Aug 14

ARS Pharmaceuticals Q2 Neffy Revenue Rises as Epinephrine Market Share Doubles

Reuters
·
Aug 14

Movement Alert|Liquidia Technologies Inc Falls 5.06% in Regular Trading, Q2 EPS Misses Expectations Triggering Profit-Taking

Market Focus
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

TIPRANKS
·
Aug 13